, Volume 52, Issue 9, pp 1971-1973,
Open Access This content is freely available online to anyone, anywhere at any time.

Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study